Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension


      The use of nitric oxide as an agent to reduce pulmonary artery pressure in a pregnancy complicated by pulmonary hypertension is reported for the first time. This therapy can reduce pulmonary vascular resistance and therefore potentially enable the right ventricle to better compensate for the physiologic changes of pregnancy. (Am J Obstet Gynecol 1999;180:1045-6.)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Chen EP
        • Bittner HB
        • Davis RD
        • Van Trigt P.
        Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension.
        J Surg Res. 1997; 69: 288-294
        • Channick RN
        • Newhart JW
        • Johnson FW
        • Williams PJ
        • Auger WR
        • Fedullo PF
        • et al.
        Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests.
        Chest. 1996; 109: 1545-1549